A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine
Clinical trial NCT03450915 · COMPLETED
Trial details
- NCT number
- NCT03450915
- Sponsor
- BiondVax Pharmaceuticals ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-07-02
- Enrollment
- 12460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.